| 000 | 06227nam a22004453i 4500 | ||
|---|---|---|---|
| 001 | EBC5152964 | ||
| 003 | MiAaPQ | ||
| 005 | 20240729131611.0 | ||
| 006 | m o d | | ||
| 007 | cr cnu|||||||| | ||
| 008 | 240724s2017 xx o ||||0 eng d | ||
| 020 |
_a9783319632728 _q(electronic bk.) |
||
| 020 | _z9783319632711 | ||
| 035 | _a(MiAaPQ)EBC5152964 | ||
| 035 | _a(Au-PeEL)EBL5152964 | ||
| 035 | _a(CaPaEBR)ebr11472020 | ||
| 035 | _a(OCoLC)1013825593 | ||
| 040 |
_aMiAaPQ _beng _erda _epn _cMiAaPQ _dMiAaPQ |
||
| 050 | 4 | _aRC666-701.2 | |
| 082 | 0 | _a616.132 | |
| 100 | 1 | _aFuchs, Flávio Danni. | |
| 245 | 1 | 0 |
_aEssentials of Hypertension : _bThe 120/80 Paradigm. |
| 250 | _a1st ed. | ||
| 264 | 1 |
_aCham : _bSpringer International Publishing AG, _c2017. |
|
| 264 | 4 | _c©2018. | |
| 300 | _a1 online resource (161 pages) | ||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 505 | 0 | _aIntro -- Preface -- Acknowledgments -- Contents -- 1: Risks of High Blood Pressure and Goals for Treatment -- 1.1 Risks for Coronary Heart Disease, Stroke, and Cardiovascular Mortality -- 1.2 Other Risks of High Blood Pressure -- 1.2.1 Heart Failure -- 1.2.2 Aortic Valve Stenosis and other heart valve diseases -- 1.2.3 Atrial Fibrillation -- 1.2.4 Aortic Stiffness and Aortic Syndromes -- 1.2.5 Peripheral Arterial Disease -- 1.2.6 Chronic Kidney Disease -- 1.2.7 Dementias -- 1.2.8 Diabetes Mellitus -- 1.2.9 Age-Related Macular Degeneration -- 1.2.10 Erectile Dysfunction -- 1.3 Populations at Risk and Trends in High Blood Pressure -- 1.4 Diagnostic Thresholds: Recommendations from Hypertension Guidelines -- 1.5 Proof of Concept: Experimental Evidence -- 1.6 Goals for Treatment and the J-Shaped Phenomenon -- 1.7 SPRINT -- 1.8 Benefits of Treating Prehypertension -- 1.9 Low Blood Pressure: The Key to a Long and Healthier Life -- 1.10 Misconceptions and Lack of Action -- 1.11 Blood Pressure Classification -- References -- 2: Pathogenesis -- 2.1 Maladaptation to Sodium Overload -- 2.1.1 Epidemiological Evidence -- 2.1.2 Salt Sensitivity -- 2.1.3 The Central Role of the Kidneys in the Pathogenesis of Hypertension -- 2.1.4 Proof of Concept: The Role of Intrinsic Renal Capacity to Handle Salt Overload in the Pathogenesis of Hypertension -- 2.2 Excessive Adiposity -- 2.3 Diabetes and Metabolic Syndrome -- 2.4 Potassium and Other Dietary Factors -- 2.5 Alcohol, Hypertension, and Cardiovascular Disease -- 2.6 Sleep Disorders -- 2.7 Stress -- 2.8 Other Risks for Hypertension -- 2.8.1 Socioeconomic and Educational Risks -- 2.8.2 Depression -- 2.8.3 Oral Contraceptives -- 2.8.4 Shift Work -- 2.8.5 Endothelial Dysfunction -- 2.8.6 Oxidative Stress and Inflammation -- 2.8.7 Other Risks -- References. | |
| 505 | 8 | _a3: Diagnosis and Evaluation -- 3.1 Blood Pressure Measurement -- 3.2 Daily Blood Pressure Load and the Concept of Casual and Usual Blood Pressure -- 3.3 Precision of Methods Used to Estimate Risks of High Blood Pressure -- 3.4 White-Coat and Masked Hypertension -- 3.4.1 Diagnostic Thresholds for Out-of-Office Blood Pressure Measurement -- 3.5 Clinical Evaluation -- 3.5.1 Headache -- 3.5.2 Epistaxis -- 3.5.3 Quality of Life -- 3.5.4 Musculoskeletal Complaints -- 3.5.5 Other Findings in the Medical History -- 3.5.6 Physical Examination -- 3.5.7 Laboratory Data -- 3.6 Risk Stratification -- 3.6.1 Electrocardiography -- 3.6.2 Echocardiography -- 3.6.3 Development of Clinical Disease -- 3.6.4 Optic Fundus Abnormalities -- 3.6.5 Aortic Stiffness and Peripheral Arterial Disease -- 3.7 Blood Pressure Variability -- 3.8 Resistant Hypertension -- 3.9 Secondary Hypertension -- References -- 4: Prevention and Treatment -- 4.1 Nonpharmacological Therapies -- 4.1.1 Reduction of Salt Intake -- 4.1.1.1 In Populations -- 4.1.1.2 In Individuals with Normal and High Blood Pressure -- 4.1.2 Hypocaloric Diet -- 4.1.3 DASH Diet -- 4.1.4 PREDIMED Diet -- 4.1.5 Supplementation of Potassium, Calcium, and Magnesium -- 4.1.6 Comparative Effectiveness of Dietary Interventions -- 4.1.7 Other Nutritional Interventions -- 4.1.7.1 Alcoholic Beverage Consumption -- 4.1.7.2 Chocolate and Other Cocoa Products -- 4.1.7.3 Other Nutraceuticals -- 4.1.7.4 Probiotics -- 4.1.8 Physical Activity -- 4.1.9 Treatment of Obstructive Sleep Apnea as a Means to Treat Hypertension -- 4.1.10 Oral Contraceptives and Hormone Replacement Therapy -- 4.1.11 Surgical Treatment of Hypertension -- 4.1.11.1 Renovascular Hypertension -- 4.1.11.2 Renal Sympathetic Denervation -- 4.1.11.3 Bariatric Surgery -- 4.1.12 Other Nonpharmacological Treatments. | |
| 505 | 8 | _a4.1.12.1 Behavioral Therapies -- 4.1.12.2 Acupuncture -- 4.1.12.3 Device-Guided Breathing Modulation -- 4.2 Drug Treatment -- 4.2.1 Pioneering Studies -- 4.2.2 The First Choice -- 4.2.3 Diuretic Preference and Association with Potassium-Sparing Agents -- 4.2.4 Other Options for the First Choice -- 4.2.5 Second-Line and Third-Line Drugs for Management of Hypertension -- 4.2.6 Management of Resistant Hypertension -- 4.2.7 Adverse Events, Adverse Effects, and the Nocebo Effect -- 4.2.8 Hypertensive Crises, Urgencies, and Emergencies -- 4.2.9 Strategies to Improve Adherence to Treatment -- 4.2.9.1 Self-Monitoring of Blood Pressure -- 4.2.9.2 Telemonitoring -- 4.2.9.3 Pharmacist Care -- 4.2.9.4 Text Messages -- References -- Erratum to: Diagnosis and Evaluation -- Index. | |
| 588 | _aDescription based on publisher supplied metadata and other sources. | ||
| 590 | _aElectronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. | ||
| 650 | 0 | _aHypertension. | |
| 655 | 4 | _aElectronic books. | |
| 776 | 0 | 8 |
_iPrint version: _aFuchs, Flávio Danni _tEssentials of Hypertension _dCham : Springer International Publishing AG,c2017 _z9783319632711 |
| 797 | 2 | _aProQuest (Firm) | |
| 856 | 4 | 0 |
_uhttps://ebookcentral.proquest.com/lib/orpp/detail.action?docID=5152964 _zClick to View |
| 999 |
_c132909 _d132909 |
||